EUVIMEDEUVIMED entdecken
Crossref

TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers

Rita Bonfiglio, Valeria Palumbo, Francesca Servadei iD, Erica Giacobbi iD, Lukas Funke, Jonathan Woodsmith, Pier Luigi Bove, Enrico Finazzi Agrò, Simone Albisinni, Oreste Claudio Buonomo, Giuseppe S Sica, Eleonora Candi und 3 weitere

Journal of Molecular Medicine · 2026-12 · 104 (1)

DOI: 10.1007/s00109-026-02733-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 11.11.2026. Verfasst von Rita Bonfiglio und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, 00133, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Suppressor Protein p53, Breast Neoplasms, Kidney Neoplasms. Die Arbeit nennt 42 Literaturangaben. Gefördert von: European Union NextGenerationEU, Ministero dell'Università e della Ricerca, Ministero dell’Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whether p53-driven immune modulation represents a conserved biological programme or a context-dependent adaptation of the tumour microenvironment remains unresolved across human cancers. To address this question, we investigated the relationship between TP53 expression, p53 pathway activity and immune microenvironmental features in breast, colorectal and kidney cancers through integrated transcriptomic, histological and bioinformatic analyses. Our findings revealed striking tumour-specific patterns of p53-associated immune regulation. Breast cancer showed no significant relationship between TP53 expression, p53 pathway activity and immune infiltration or immune checkpoint expression, consistent with an intrinsically immune-cold microenvironment. In contrast, colorectal cancer exhibited a paradoxical immune-restricted phenotype in which p53 pathway activation coexisted with increased cytotoxic lymphocyte infiltration while simultaneously associating with the upregulation of the inhibitory checkpoints TIM-3 and VISTA. Analyses of public colorectal cancer datasets showed frequent TP53 mutations and higher TP53 transcript expression in primary tumours and metastatic lesions than in normal colon tissue. Kidney cancer displayed a distinct stromal-centred pattern, where TP53 expression, but not p53 pathway activity, was associated with fibroblast enrichment and increased expression of immunoregulatory checkpoints. In conclusion, this study reveals distinct associations between p53 signalling and immune microenvironmental features, supporting a context-dependent role of p53 in tumour immune regulation. These data may inform future studies exploring the integration of p53-related biomarkers with immunotherapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor Suppressor Protein p53Breast NeoplasmsKidney NeoplasmsHumansFemaleTumor MicroenvironmentGene Expression Regulation, NeoplasticPhenotypeSignal TransductionGene Expression ProfilingMutationHepatitis A Virus Cellular Receptor 2

Stichwörter der Autor:innen

Immune checkpointsImmunotherapyTIM-3TP53Tumour immune microenvironmentVISTA

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanHepatitis A Virus Cellular Receptor 2

Autor:innen und Institutionen

  • Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, 00133, Italy.
  • Indivumed GmbH, Falkenried, Hamburg, Germany.
  • Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.
  • Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy.
  • Division of Breast Unit, Department of Surgical Sciences, School of Medicine and Surgery, Tor Vergata University of Rome, Rome, 00133, Italy.
  • Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, 00133, Italy. alessandro.mauriello@uniroma2.it.

ORCID-Profile: Francesca Servadei, Erica Giacobbi

Förderung

  • European Union NextGenerationEU
  • Ministero dell'Università e della Ricerca
  • Ministero dell’Università e della Ricerca

Zitieren

APA

Bonfiglio, R., Palumbo, V., Servadei, F., Giacobbi, E., Funke, L., Woodsmith, J., Bove, P. L., Agrò, E. F., Albisinni, S., Buonomo, O. C., Sica, G. S., Candi, E., Melino, G., Mauriello, A., & Scimeca, M. (2026). TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers. Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-026-02733-2

Vancouver

Bonfiglio R, Palumbo V, Servadei F, Giacobbi E, Funke L, Woodsmith J, et al. TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers. Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-026-02733-2

BibTeX
@article{Bonfiglio2026,
  author = {Bonfiglio, Rita and Palumbo, Valeria and Servadei, Francesca and Giacobbi, Erica and Funke, Lukas and Woodsmith, Jonathan and Bove, Pier Luigi and Agrò, Enrico Finazzi and Albisinni, Simone and Buonomo, Oreste Claudio and Sica, Giuseppe S and Candi, Eleonora and Melino, Gerry and Mauriello, Alessandro and Scimeca, Manuel},
  title = {TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers},
  journal = {Journal of Molecular Medicine},
  year = {2026},
  volume = {104},
  number = {1},
  doi = {10.1007/s00109-026-02733-2}
}
Kostenlos starten →